Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Emma H A, Stahlie"'
Autor:
Maartje W. Rohaan, Emma H. A. Stahlie, Viola Franke, Lisanne P. Zijlker, Sofie Wilgenhof, Vincent van der Noort, Alexander C. J. van Akkooi, John B. A. G. Haanen
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Trials investigating neoadjuvant treatment with immune checkpoint inhibitors (ICI) in patients with melanoma have shown high clinical and pathologic response rates. Treatment with talimogene laherparepvec (T-VEC), a modified herpe
Externí odkaz:
https://doaj.org/article/7d1e6b458ad644d8942e1babbaf34492
Autor:
Viola, Franke, Emma H A, Stahlie, Willem M C, Klop, Charlotte L, Zuur, Danique M S, Berger, Bernies, van der Hiel, Bart A, van de Wiel, Michel W J M, Wouters, Winan J, van Houdt, Alexander C J, van Akkooi
Publikováno v:
Melanoma Research. 33:66-70
Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, type 1, intralesionally administered in patients with stage IIIB/C-IVM1a unresectable melanoma. When surgery is not a treatment option in the head and neck region, T-VEC can be an e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::435776695b7927730672cd3cf881b871
https://doi.org/10.1097/cmr.0000000000000866
https://doi.org/10.1097/cmr.0000000000000866
Autor:
Richard J. B. Walker, Nicole J. Look Hong, Marc Moncrieff, Alexander C. J. van Akkooi, Evan Jost, Carolyn Nessim, Winan J. van Houdt, Emma H. A. Stahlie, Chanhee Seo, May Lynn Quan, J. Gregory McKinnon, Frances C. Wright, Michail N. Mavros
Publikováno v:
Annals of Surgical Oncology. 29:7010-7017
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a040f0c57a50df123ba98b4753f3ea5
https://doi.org/10.1245/s10434-022-11936-z
https://doi.org/10.1245/s10434-022-11936-z
Autor:
Viola, Franke, Emma H A, Stahlie, Bernies, van der Hiel, Bart A, van de Wiel, Michel W J M, Wouters, Winan J, van Houdt, Alexander C J, van Akkooi
Publikováno v:
Journal of Immunotherapy. 45:263-266
Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus type 1, which can be administered intralesionally in patients with stage IIIB/C-IVM1a (American Joint Committee of Cancer; AJCC 7th edition) unresectable melanoma. In the case of dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f75071dad0d2cc90452547d85ba79a7
https://doi.org/10.1097/cji.0000000000000423
https://doi.org/10.1097/cji.0000000000000423
Autor:
Amod A. Sarnaik, Young-Chul Kim, Michael C. Lowe, Giorgos C. Karakousis, James Sun, Emma H. A. Stahlie, Alexander C.J. van Akkooi, Kristin Baecher, David W. Ollila, Frances A. Collichio, Jonathan S. Zager, Syeda Mahrukh Hussnain Naqvi, Luke D. Rothermel, Richard J. Straker, G. Paul Wright, Danielle DePalo, Michael J Carr, Yun Song, Keith A. Delman, Raphael J. Louie
Publikováno v:
Annals of Surgical Oncology. 29:791-801
Talimogene laherparepvec (T-VEC) is an oncolytic virus approved for the treatment of unresectable, recurrent melanoma. The role of T-VEC after progression on systemic immunotherapy (IO) remains undefined. The goal of this study was to characterize th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5ee131299c2a7c78e5270e401a4d0c9
https://doi.org/10.1245/s10434-021-10910-5
https://doi.org/10.1245/s10434-021-10910-5
Autor:
A.C.J. van Akkooi, B.A. van de Wiel, B. van der Hiel, Yvonne Schrage, Michel W.J.M. Wouters, Emma H. A. Stahlie, Annemarie Bruining, W.J. van Houdt
Publikováno v:
European Journal of Surgical Oncology. 47:1157-1162
Background Stage IIB/IIC (8th AJCC) melanoma patients are known to have high-risk primary tumors, however they follow the same routine to sentinel lymph node biopsy (SLNB) as more low risk tumors. Guidelines are not conclusive regarding the use of pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3124c947baee2679eab623bd276b0648
https://doi.org/10.1016/j.ejso.2020.12.007
https://doi.org/10.1016/j.ejso.2020.12.007
Autor:
Richard J. B. Walker, Nicole J. Look Hong, Marc Moncrieff, Alexander C. J. van Akkooi, Evan Jost, Carolyn Nessim, Winan J. van Houdt, Emma H. A. Stahlie, Chanhee Seo, May Lynn Quan, J. Gregory McKinnon, Frances C. Wright, Michail N. Mavros
Publikováno v:
Annals of surgical oncology. 29(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32677eb6bf53a027f27aaf43347a76a1
https://pubmed.ncbi.nlm.nih.gov/35810221
https://pubmed.ncbi.nlm.nih.gov/35810221
Autor:
Yvonne Schrage, Emma H. A. Stahlie, Bernies van der Hiel, Marcel P. M. Stokkel, Michel W.J.M. Wouters, Alexander C.J. van Akkooi, Winan J. van Houdt
Publikováno v:
Journal of Surgical Oncology. 122:1328-1336
Background The role of surveillance imaging in high-risk stage III melanoma patients after complete surgical resection remains controversial, and with the advent of adjuvant therapy, it may also be expanded. Therefore, we evaluated two fluorine-18 fl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06628dc3d5de4665a9bb36dd7153b196
https://doi.org/10.1002/jso.26155
https://doi.org/10.1002/jso.26155
Publikováno v:
Annals of surgical oncology. 29(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dfaa28c0041b069f4fe3fa18e40a2a8e
https://pubmed.ncbi.nlm.nih.gov/35000081
https://pubmed.ncbi.nlm.nih.gov/35000081
Publikováno v:
Annals of surgical oncology. 29(3)
Talimogene Laherparepvec (T-VEC) is a modified herpes simplex virus type-1 used as intralesional immunotherapy in stage IIIB-IVM1a melanoma patients. Recently, Stahlie et al. published a predictive model for complete response (CR) to T-VEC. This stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e85f7a1259fe237f5380db8ffe3be07a
https://pubmed.ncbi.nlm.nih.gov/34816368
https://pubmed.ncbi.nlm.nih.gov/34816368